Avidity Biosciences
206 hedge funds and large institutions have $3.86B invested in Avidity Biosciences in 2025 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 84 increasing their positions, 74 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
6% less funds holding
Funds holding: 218 → 206 (-12)
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
27% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 37
Holders
206
Holding in Top 10
7
Calls
$10.4M
Puts
$4.22M
Top Buyers
| 1 | +$100M | |
| 2 | +$27.4M | |
| 3 | +$24.8M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$17M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$16.2M |
Top Sellers
| 1 | -$37.5M | |
| 2 | -$25.5M | |
| 3 | -$18.4M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$17.6M |
| 5 |
BlackRock
New York
|
-$16.5M |
